Last update:

Oncology & Cancer news

Oncology & Cancer

Antidepressant shows promise for treating brain tumors

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, ...

Oncology & Cancer

Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma

A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic ...

Oncology & Cancer

New prostate biopsy technique lowers infection risk

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators has shown that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with ...

Oncology & Cancer

Adjuvant durvalumab extends survival in small cell lung cancer

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to a study published online Sept. 13 in the New England ...

Oncology & Cancer

What you should know about prostate cancer screening

The prostate is a small gland in males that aids in reproduction. Prostate cancer is one of the most common types of cancer, and when it's detected early, often by a simple blood test, it has the best chance for successful ...

Oncology & Cancer

Lowering cancer drug dose could open tumors to immunotherapy

Research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the tumor's response to immunotherapy.

Oncology & Cancer

New drug target discovered for aggressive form of prostate cancer

Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease—it could be a new target for treatment and be used to help predict who will become resistant to hormone therapy.

Oncology & Cancer

Clinical trial: Preventing heart injury caused by anticancer drugs

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) used to prevent the cardiotoxic effects of anthracycline-based chemotherapy in patients with lymphoma.

Oncology & Cancer

Genetics play big role in ovarian cancer

In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce, a gynecologic oncologist at Penn State Cancer Institute. The ...

Oncology & Cancer

How the immune system fails as cancer arises

Cancer has been described as "a wound that does not heal," implying that the immune system is unable to wipe out invading tumor cells. A new discovery confirms that a key molecule can reprogram immune cells that normally ...